Exponent, Inc. (NASDAQ:EXPO) insider Harri Kytomaa sold 7,000 shares of the business’s stock in a transaction on Friday, October 26th. The stock was sold at an average price of $49.00, for a total value of $343,000.00. Following the completion of the transaction, the insider now directly owns 13,090 shares of the company’s stock, valued at $641,410. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
NASDAQ EXPO opened at $49.05 on Tuesday. Exponent, Inc. has a fifty-two week low of $34.90 and a fifty-two week high of $54.58. The firm has a market capitalization of $2.55 billion, a PE ratio of 45.84 and a beta of 0.56.
Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, October 18th. The business services provider reported $0.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.03. Exponent had a return on equity of 20.92% and a net margin of 13.98%. The company had revenue of $88.71 million during the quarter, compared to analysts’ expectations of $88.52 million. During the same period in the previous year, the firm posted $0.27 earnings per share. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that Exponent, Inc. will post 1.31 EPS for the current year.
A number of equities analysts have recently weighed in on the company. Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $55.00 price target for the company in a report on Monday, October 22nd. BidaskClub cut Exponent from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 20th. Berenberg Bank assumed coverage on Exponent in a report on Wednesday, September 12th. They issued a “buy” rating for the company. Finally, SunTrust Banks boosted their price target on Exponent to $56.00 and gave the stock a “buy” rating in a report on Friday, July 20th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $45.00.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in EXPO. Sei Investments Co. raised its holdings in shares of Exponent by 45.0% in the first quarter. Sei Investments Co. now owns 7,387 shares of the business services provider’s stock worth $580,000 after acquiring an additional 2,291 shares during the last quarter. Stifel Financial Corp purchased a new stake in shares of Exponent in the first quarter valued at $270,000. UBS Group AG grew its position in shares of Exponent by 17.2% in the first quarter. UBS Group AG now owns 43,036 shares of the business services provider’s stock valued at $3,385,000 after purchasing an additional 6,308 shares during the period. Legal & General Group Plc grew its position in shares of Exponent by 1.8% in the first quarter. Legal & General Group Plc now owns 53,727 shares of the business services provider’s stock valued at $4,218,000 after purchasing an additional 932 shares during the period. Finally, Royal Bank of Canada grew its position in shares of Exponent by 10.9% in the first quarter. Royal Bank of Canada now owns 32,375 shares of the business services provider’s stock valued at $2,546,000 after purchasing an additional 3,184 shares during the period. 88.69% of the stock is owned by institutional investors.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Featured Article: Why do companies issue stock splits?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.